Related Experiment Video
Updated: Aug 13, 2026

An Assay for Quantifying Protein-RNA Binding in Bacteria
Published on: June 12, 2019
The methyl-CpG binding protein MBD1 is required for PML-RARalpha function
Raffaella Villa1, Lluis Morey, Veronica A Raker
1Centre de Regulacio Genomica, Universitat Pompeu Fabra, Passeig Maritim 37-49, 08003 Barcelona, Spain.
Abstract:
PML-RARalpha induces a block of hematopoietic differentiation and acute promyelocytic leukemia. This block is based on its capacity to inactivate target genes by recruiting histone deacetylase (HDAC) and DNA methyltransferase activities. Here we report that MBD1, a member of a conserved family of proteins able to bind methylated DNA, cooperates with PML-RARalpha in transcriptional repression and cellular transformation. PML-RARalpha recruits MBD1 to its target promoter through an HDAC3-mediated mechanism. Binding of HDAC3 and MBD1 is not confined to the promoter region but instead is spread over the locus. Knock-down of HDAC3 expression by RNA interference in acute promyelocytic leukemia cells alleviates PML-RAR-induced promoter silencing. We further demonstrate that retroviral expression of dominant-negative mutants of MBD1 in hematopoietic precursors compromises the ability of PML-RARalpha to block their differentiation and thus restored cell differentiation. Our results demonstrate that PML-RARalpha functions by recruiting an HDAC3-MBD1 complex that contributes to the establishment and maintenance of the silenced chromatin state.
Insights
PML-RARalpha causes acute promyelocytic leukemia by silencing genes. Researchers found that MBD1 and HDAC3 proteins cooperate with PML-RARalpha to maintain this gene silencing, blocking cell differentiation.
Area of Science:
- Molecular Biology
- Hematology
- Epigenetics
Background:
- PML-RARalpha fusion protein drives acute promyelocytic leukemia (APL).
- Gene silencing via histone deacetylase (HDAC) and DNA methyltransferase recruitment underlies PML-RARalpha's function.
- Understanding the molecular mechanisms of PML-RARalpha-mediated transcriptional repression is crucial for APL treatment.
Purpose of the Study:
- To investigate the role of MBD1 (methyl-CpG binding domain protein 1) in PML-RARalpha-induced transcriptional repression and cellular transformation.
- To elucidate the mechanism by which PML-RARalpha recruits MBD1 and its associated factors.
Main Methods:
- RNA interference (RNAi) for HDAC3 knockdown in APL cells.
- Retroviral expression of dominant-negative MBD1 mutants in hematopoietic precursors.
- Chromatin immunoprecipitation (ChIP) to assess protein binding across gene loci.
- Analysis of hematopoietic differentiation and gene expression.
Main Results:
- MBD1 cooperates with PML-RARalpha in transcriptional repression and cellular transformation.
- PML-RARalpha recruits MBD1 via an HDAC3-mediated mechanism to target gene promoters and loci.
- HDAC3 knockdown alleviates PML-RARalpha-induced promoter silencing.
- Expression of dominant-negative MBD1 mutants restores hematopoietic differentiation in the presence of PML-RARalpha.
Conclusions:
- PML-RARalpha functions by recruiting an HDAC3-MBD1 complex.
- This complex establishes and maintains the silenced chromatin state essential for APL development.
- Targeting the HDAC3-MBD1 complex may offer a therapeutic strategy for APL.
Related Concept Videos
Abnormal Proliferation
Master Transcription Regulators
Regulation of Nuclear Protein Sorting

